We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
-4.81%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$61.4M
AUM Growth
+$421K
Cap. Flow
+$908K
Cap. Flow %
1.48%
Top 10 Hldgs %
36.09%
Holding
98
New
30
Increased
15
Reduced
28
Closed
20

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$2.57M
2
HCA icon
HCA Healthcare
HCA
+$2.24M
3
AAPL icon
Apple
AAPL
+$1.87M
4
ELV icon
Elevance Health
ELV
+$1.51M
5
GILD icon
Gilead Sciences
GILD
+$1.48M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$2.49M
2
AER icon
AerCap
AER
+$2.11M
3
WBA
Walgreens Boots Alliance
WBA
+$1.64M
4
SCHW
Charles Schwab
SCHW
+$1.53M
5
TXT icon
Textron
TXT
+$1.1M

Sector Composition

Rank Sector Weight
1 Healthcare 47.78%
2 Technology 12.67%
3 Financials 6.92%
4 Communication Services 6.07%
5 Consumer Discretionary 3.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IBB icon
51
iShares Biotechnology ETF
IBB
$9.77B
$327K 0.53%
+3,765
New +$337K
HOLX
52
DELISTED
Hologic
HOLX
$317K 0.52%
9,194
-16,294
-64% -$568K
ACOR
53
DELISTED
Acorda Therapeutics
ACOR
$296K 0.48%
93
-140
-60% -$581K
GBT
54
DELISTED
Global Blood Therapeutics, Inc.
GBT
$267K 0.43%
16,848
+1,214
+8% +$21.6K
HDP
55
DELISTED
Hortonworks, Inc.
HDP
$260K 0.42%
23,010
+4,440
+24% +$52K
DXCM icon
56
DexCom
DXCM
$32B
$258K 0.42%
15,192
-1,592
-9% -$26.6K
CLVS
57
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
$257K 0.42%
13,400
+7,900
+144% +$167K
KITE
58
DELISTED
Kite Pharma, Inc.
KITE
$254K 0.41%
5,542
-3,885
-41% -$188K
AMSG
59
DELISTED
Amsurg Corp
AMSG
$241K 0.39%
+3,230
New +$227K
MKTX icon
60
MarketAxess Holdings
MKTX
$5.72B
$227K 0.37%
+1,819
New +$208K
CBRE icon
61
CBRE Group
CBRE
$42.9B
$220K 0.36%
+7,644
New +$210K
AMT icon
62
American Tower
AMT
$80.4B
$219K 0.36%
+2,136
New +$200K
BABA icon
63
Alibaba
BABA
$308B
$219K 0.36%
2,769
-14,841
-84% -$1.04M
PXD
64
DELISTED
Pioneer Natural Resource Co.
PXD
$217K 0.35%
+1,540
New +$191K
CRUS icon
65
Cirrus Logic
CRUS
$6.26B
$168K 0.27%
+4,627
New +$150K
MYOK
66
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$166K 0.27%
15,500
-103
-0.7% -$937
ACHC icon
67
Acadia Healthcare
ACHC
$2.94B
$152K 0.25%
+2,765
New +$158K
SAGE
68
DELISTED
Sage Therapeutics
SAGE
$135K 0.22%
+4,201
New +$148K
DMTX
69
DELISTED
Dimension Therapeutics, Inc
DMTX
$125K 0.2%
16,300
-2,326
-12% -$18.3K
VYGR icon
70
Voyager Therapeutics
VYGR
$198M
$120K 0.2%
14,335
-49
-0.3% -$556
JD icon
71
JD.com
JD
$44.5B
$106K 0.17%
+3,985
New +$105K
SPNC
72
DELISTED
Spectranetics Corp
SPNC
$89K 0.15%
+6,160
New +$85.3K
KURA icon
73
Kura Oncology
KURA
$850M
$81K 0.13%
20,022
-28,726
-59% -$136K
AER icon
74
AerCap
AER
$23.8B
– –
-48,829
Closed -$2.11M
BLUE
75
DELISTED
bluebird bio
BLUE
– –
-867
Closed -$721K
1 2
3
4

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q1 2016 Portfolio in Review

As of Q1 2016, Partner Investment Management held 98 positions worth $61.4M, up 0.69% from $61M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Partner Investment Management's Q1 2016 filing shows 30 new, 15 increased, 28 reduced and 20 closed positions. Its largest new stake was AbbVie: 46,029 shares worth $2.63M. The largest sale was Teva Pharmaceuticals, an estimated $2.49M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, down from 51% a quarter earlier, followed by Technology and Financials.

  • Partner Investment Management's largest Q1 2016 buy was AbbVie: 46,029 shares worth $2.63M.
  • Partner Investment Management added most to HCA Healthcare in Q1 2016, an estimated $2.24M increase.
  • Partner Investment Management's biggest Q1 2016 reduction was Walgreens Boots Alliance, cutting an estimated $1.64M.
  • Partner Investment Management fully exited Teva Pharmaceuticals in Q1 2016, selling an estimated $2.49M.
  • Partner Investment Management's ten largest holdings make up 36% of its $61.4M portfolio in Q1 2016.
  • Partner Investment Management opened 30 new positions and closed 20 in Q1 2016.
  • Partner Investment Management's portfolio value rose 0.69% quarter-over-quarter to $61.4M.

Based on Partner Investment Management's 13F filing for Q1 2016, filed 16 May 2016.